¹B°Ê¥Í²z¶g°T(²Ä394´Á)
¨Å鬡°Ê¡BÅé¾A¯à»PÂåÀø¸ê·½(October 1, 2019)
¤è¶i¶© ¥xÆW®v¤j¦WÅA±Ð±Â
³ü¡B «e¨¥
¡@¡@±q¨Æ¨¬°÷¨Å鬡°Ê¥i¥H´î§CÂåÀø¶O¥Î¡H¤ßªÍ¥\¯à¤ñ¸û¦nªº¤HÂåÀø¶O¥Î·|´î¤Ö¡H¨Å鬡°Ê¸û¦h©Î¤ßªÍ¥\¯à¸û¨ÎªÌÂåÀø¸ê·½¨Ï¥Î (¦p«æ¶E¡Bªù¶E©Î¦í°|) ªº¾÷²v¸û¤Ö¡H¯e¯f (¦p¤ßŦ¯f) ±wªÌ¨C¦~ªºÂåÀø¶O¥Î©M¤@¯ë¤H¬Û®t¦h¤Ö¡H¯e¯f±wªÌ¦pªG±q¨Æ¾A«×¹B°Ê¡A·|¸`¬ÙÂåÀø¤ä¥X¡H¦p·|¡A·|´î§C¦h¤Ö¡H¦pªG¥Á²³±q¨Æ¨¬°÷ªº¨Å鬡°Ê¶q¡A·|´î§C¾ãÅéÂåÀø¶O¥Î¦h¤Ö¦Ê¤À¤ñ¡HÃþ¦ü³oÃþªº°ÝÃD¡A¦b°ªÄ֤κC©Ê¯e¯f¤H¤fº¥¼W¡A¦ý°ê®a¾ãÅé¸ê·½¦³ªºÂù«À£¤O¤U¡A¤w³Q°ª«×Ãöª`¡C
¡@¡@¨Å鬡°Ê¡BÅé¾A¯à©M°·±dª¬ªp (¥]¬AºC©Ê¯e¯f) ¦³±K¤Á¬ÛÃö¡A¨Å鬡°Ê¶V¦h©Î±q¨Æ³W«ß¹B°Ê¡A¥i¥H´£¤ÉÅé¾A¯à (¥]¬A¤ßªÍ¥\¯à)¡B«P¶i°·±d©M¹w¨¾¯e¯f¡C³B¦b°ª¬ì§Þ©M¸ê°T®É¥N¡A¥Á²³ªº¥Í¬¡¤è¦¡ÁͦV©óÀRºA¡A¤j³¡¤À¤Hªº¨Å鬡°Ê¤£¨¬¡A¥[¤WÀ£¤Oµ¥¦]¯À¡A³\¦h¤HªºÅé¾A¯à»P°·±dª¬ªp«G°_¬õ¿O¡A¬Æ¦Ü¿©±wºC©Ê¯e¯f¡C³ø§i«ü¥X¤j³¡¤Àªº°ªÄ֪̩M¤@¥bªº¦¨¦~¤H¦³¤@ºØ¥H¤WªººC©Ê¯e¯f¡A¦Ó¤QºØ±`¨£ªººC©Ê¯e¯f¡A¨ä¤¤¤CºØ·|¦]¬°³W«ß¹B°Ê¦ÓÀò±o¦³®Ä§ïµ½ (U.S. Department of Health and Human Service, 2018)¡CÂǵ۳W«ß¹B°Ê©M°ÊºA¥Í¬¡¤è¦¡¨Ó«P¶i°·±d¡A¶i¦Ó´î¤ÖÂåÀøt¾áªº²z©À¡A¤]¶V¨Ó¶V¨ü¨ì«µø¡C
¡@¡@¡u¦³¤@¤ÀÃÒ¾Ú¡A»¡¤@¤À¸Ü¡v¡A¹L¥h§Ṵ́Q½×¨Å鬡°Ê¡BÅé¾A¯à»PÂåÀø¸g¶OªºÄ³ÃD¡A¥u¯à°Ñ¦Ò¦³ªº¤åÄm©Î¸ê®Æ¡AÅÞ¿è©Êªº¥h¥[¥H±À´ú¡A¦p¨Å鬡°Ê¶V¦h©Î¦³³W«ß¹B°Êªº¤H¥i¥H´î¤ÖÂåÀø¤ä¥X©M¸ê·½¨Ï¥Î¡A¦ý¨Ã¨S¦³¨ãÅé¥i¶q¤Æªº¬ã¨sÃÒ¾Ú¥[¥H¤ä«ù¡C¥Ñ©ó¥H«e¬ÛÃöªº¬ã¨s«Ü¤Ö¡A¥»¤å¦¬¶°3½g©ó2015¦~«áµoªíªº¤åÄm¡A°w¹ï¬ã¨sªº²Ó¸`§@¨t²Î©Ê¾ã²z©M»¡©ú¡A§Æ±æ¯à°÷´£¨Ñ¬ÛÃö¤Hû°Ñ¦Ò¡A¦Ó¯à§ó¤F¸Ñ¨Å鬡°Ê©MÅé¾A¯à¹ï©óÂåÀø¸g¶O»P¸ê·½¦³®Ä¨Ï¥Îªº°^Äm»P«n©Ê¡C
¶L¡B ¨Å鬡°Ê¶q»P°·±d·ÓÅ@¤ä¥X
¡@¡@¨Å鬡°Ê¶q¤£¨¬¬O§_·|¼W¥[°·±d·ÓÅ@¤ä¥X¡H¦pªG·|¡A¼vÅTªº´T«×¦³¦h¤j¡H¥dº¸´Ë¯Çµ¥¾ÇªÌ (Carlsona et al., 2015) °w¹ï³oijÃD¡A¦¬¶°¤ÀªR¦¨¦~¤H¨Å鬡°Ê¶q»P°·±d·ÓÅ@¤ä¥X (health care expenditure) ªº¸ê®Æ¤Î¬ÛÃöijÃD¡A¥H´£¨Ñ¹êÃÒ¬ã¨s¸ê®Æ¨Ñ°Ñ¦Ò¡A¨ä¬ã¨s°Ê¾÷»P¥Øªº¡B¬ã¨s¤èªk¡Bµ²ªG¡B°Q½×©M«ØÄ³¡A»¡©ú¦p¤U¡C
¡@¡@¬ã¨s°Ê¾÷»P¥Øªº¡C¹L¥h«Ü¤Ö¬ã¨s±´°Q¨Å鬡°Ê¶q¹ï°·±d·ÓÅ@¤ä¥Xªº¼vÅT¡A¦¹¬ã¨s¤§¥Dn¥Øªº¬°¡G1. ¤ñ¸û¤£¹B°Ê¡B¨Å鬡°Ê¶q¤£¨¬©M¨Å鬡°Ê¨¬°÷ªÌ¤TÃþ¦¨¦~¤H¡A¨C¦~ªº°·±d·ÓÅ@¤ä¥X¬O§_¦³©Ò®t²§¡H2. ¤F¸Ñ¨Å鬡°Ê¶q¤£¨¬©Î¤£¹B°Ê¤§¦¨¦~¤H¡A¨ä©Ò¼W¥[¤§°·±d·ÓÅ@¤ä¥X¡A¬ù¦û¾ãÅé¶O¥Î¤§¦Ê¤À¤ñ¡C
¡@¡@¬ã¨s¤èªk¡C¹ï¶H¡G¥H 51165¦ì21·³¥H¤Wªº¬ü°ê¦¨¦~¤H¬°½Õ¬d¬ã¨s¹ï¶H¡A°Ñ»PªÌ¤£¬O¾÷ºc¦í¥Á (non-institutionalized¡A¤£¦í¦b¦w¾i°|©Î¦Ñ¦~¤§®aµ¥¾÷ºcªº¥Á²³)¡A¤]±Æ°£Ãh¥¥©Î¨S¦³¿ìªk¹B°Êªº¤H¡C¥ð¶¢®É¶¡ªº¨Å鬡°Ê¶q¡G°Ñ»PªÌªº¨Å鬡°Ê¸ê®Æ¥Ñ2004-2010¦~¥þ°ê°·±d³X°Ý½Õ¬d (National Health Interview Survey) Àò±o¡C°·±d·ÓÅ@¤ä¥X¡G°·±d·ÓÅ@¤ä¥X¸ê®Æ¡A¬O¥Ñ2006-2011¦~ÂåÀø¤ä¥X¤p²Õ (Medical Expenditure Panel Survey) ªº½Õ¬dµ²ªGÀò¨ú¡A¨Ì¾Ú¸gÀÙ´ú¶q¼Ò¦¡ (econometric model) ¥[¥H¦ôp¡C¨C¦~ªº°·±d·ÓÅ@¤ä¥X¥]¬A©Ò¦³ªA°È¶O¥Î¡A¦p¦í°|¡Bªù¶E¡B«æ¶E¡B¤ú¬ì¡B²´¬ì¡B®a¸Ì°·±d·ÓÅ@¡B³B¤èÃÄ©M¨ä¥Lµ¥¶O¥Î¡C¨Å鬡°Ê¶q¤À²Õ¡G¨Ì¾Ú¨Å鬡¶qªº«ü¾Éì«h»P«ØÄ³¡A±N¨Å鬡°Ê¶qªº¦h¹è¤À¬°¤T²Õ¡G¤£¹B°Ê²Õ (¨S¦³¨Å鬡°Ê¶q)¡B¨Å鬡°Ê¶q¤£¨¬²Õ (±q¨Æ¬Y¨Ç¨Å鬡°Ê¡A¦ý¨C¶g¨S¹F¨ì«ØÄ³¶q) ©M¨Å鬡°Ê¨¬°÷²Õ (¨C¶g¤¤µ¥¦Ü¿E¯P¨Å鬡°Ê¶q¤j©ó150¤ÀÄÁªÌ)¡C
¡@¡@¬ã¨sµ²ªG¡C¥»¬ã¨s¬O¬ü°ê¥þ°ê©Êªº¤j¼Ë¥»½Õ¬d¡A¥Dnªºµ²ªG¦p¤U¡G1. ¦b½Õ¾ã¥Dnªº¦@Åܶµ«á¡A¾ãÅéÂåÀø¤ä¥X¬ù¦³12.5%»P¨Å鬡°Ê¶q¤£¨¬ (¥]¬A¤£¹B°Ê) ¦³Ãö (¦pªí1¡A¼Ò¦¡1)¡C2. ¨C¦ì¤£¹B°ÊªÌªº°·±d·ÓÅ@¤ä¥X¡A¤ñ¨Å鬡°Ê¨¬°÷ªÌ¡A¨C¦~¼W¥[1437¬ü¤¸¡A¬Û®t29.9%¡F¦Ó¨Å鬡°Ê¶q¤£¨¬ªÌ¡A¨C¦~¼W¥[713¬ü¤¸¡A®t²§15.4%¡C¦U¨Å鬡°Ê²Õ§O¶¡ªº°·±d·ÓÅ@¶O¥Î¡A¬Ò¹FÅãµÛ®t²§¡C
ªí1¡G¦¨¦~¤H¨Å鬡°Êª¬ªp»P°·±d·ÓÅ@¤ä¥X¤ñ¸ûªí
| ¨Å鬡°Ê/°·±d·ÓÅ@¤ä¥X | ©M¨Å鬡°Ê¨¬°÷ªÌ¤ñ¸û
ªº°·±d·ÓÅ@¤ä¥X®t²§ | ¨C¤H®t²§¢H (©M¨Åé
¬¡°Ê¨¬°÷ªÌ¤ñ¸û) | ¾ãÅé°·±d·ÓÅ@
¤ä¥X¦Ê¤À¤ñ |
¼Ò¦¡1¡G
¡@½Õ¾ã¥Dn¦@Åܶµ |
| ¤£¹B°ÊªÌ | $1437 | 29.9% | 9.6% |
| ¨Å鬡°Ê¶q¤£¨¬ªÌ | $713 | 15.4% | 2.8% |
| ¨Å鬡°Ê¨¬°÷ªÌ | -- | -- | 12.5% |
¼Ò¦¡2¡G
¡@½Õ¾ã¥Dn¦@Åܶµ©MBMI |
| ¤£¹B°ÊªÌ | $1313 | 26.6% | 8.8% |
| ¨Å鬡°Ê¶q¤£¨¬ªÌ | $576 | 12.1% | 2.3% |
| ¨Å鬡°Ê¨¬°÷ªÌ | -- | -- | 11.1% |
µù¡G¥Dn¦@Åܶµ¥]¬A©Ê§O¡B¦~ÄÖ¡BºØ±Ú¡B¦a°Ï¡Bµ²±Bª¬ªp¡B±Ð¨|¡B³h½a¤ô·Ç¡B°·±d
¡@¡@«OÀI¡B©â·Ï©MEPS (Medical Expenditure Panel Survey¡AÂåÀø¤ä¥X¤p²Õ½Õ¬d) ¦~µ¥¡C
¡@¡@3. ©ó½Õ¾ã¥Dn¦@Åܶµ©MBMI«á¡A¾ãÅé°·±d·ÓÅ@¤ä¥X¬ù¦³11.1%»P¨Å鬡°Ê¶q¤£¨¬ (¥]¬A¤£¹B°Ê) ¦³Ãö (¦pªí1, ¼Ò¦¡2)¡A¬ã¨sªÌ»{¬°ªÎD©ÎÅ髹L«·|¼W¥[¤ä¥X¡A¦Ó¥[¥H½Õ¾ã¡C¨C¦ì¤£¹B°ÊªÌªº°·±d·ÓÅ@¶O¥Î¤ä¥X¤ñ¨Å鬡°Ê¨¬°÷ªÌ¡A¨C¦~¼W¥[1313¬ü¤¸¡A®t²§26.6%¡F¦Ó¨Å鬡°Ê¶q¤£¨¬ªÌ¡A¨C¦~¼W¥[¤ä¥X¤Ö576¬ü¤¸¡A®t²§12.1%¡C§Y¨Ï½Õ¾ã¥Dnªº¦@Åܶµ©MBMI¡A¦U¨Å鬡°Ê²Õ§O¶¡ªº°·±d·ÓÅ@¶O¥Î¤ä¥X¬Ò¹FÅãµÛ®t²§ (¦pªí1¡A¼Ò¦¡2)¡C
¡@¡@4. ¦pªG°Ñ»PªÌ¥h°£¦]¬°°·±d¦Ó¨S¦³¿ìªk¨«¸ôªÌ¡A¦b½Õ¾ã¥Dn¦@Åܶµ«á¡A¬ù¦³9.9%ªº¾ãÅé°·±d·ÓÅ@¤ä¥X»P¨Å鬡°Ê¶q¤£¨¬ (¨S¦³¹B°Ê»P¹B°Ê¤£¨¬) ¦³Ãö¡C¨C¦ì¤£¹B°ÊªÌ°·±d·ÓÅ@¶O¥Î¤ä¥X¡A¤ñ¨Å鬡°Ê¨¬°÷ªÌ¨C¦~¼W¥[1015¬ü¤¸¡A¬Û®t23.6%¡A¦Ó¨Å鬡°Ê¶q¤£¨¬ªÌ¡A¨C¦~¼W¥[¤ä¥X603¬ü¤¸¡A®t²§14.0%¡A¦U¨Å鬡°Ê²Õ§O¶¡ªº°·±d·ÓÅ@¶O¥Î¬Ò¹FÅãµÛ®t²§ (¦pªí2¡A¼Ò¦¡1)¡C
ªí2¡G¦¨¦~¤H¨Å鬡°Êª¬ªp»P°·±d·ÓÅ@¤ä¥X¤ñ¸ûªí (±Æ°£¨«¸ô¦³§xÃøªÌ)
| ¨Å鬡°Ê/°·±d·ÓÅ@¤ä¥X | ©M¨Å鬡°Ê¨¬°÷ªÌ¤ñ¸û
ªº°·±d·ÓÅ@¤ä¥X®t²§ | ¨C¤H®t²§¢H (©M¨Åé
¬¡°Ê¨¬°÷ªÌ¤ñ¸û) | ¾ãÅé°·±d·ÓÅ@
¤ä¥X¦Ê¤À¤ñ |
¼Ò¦¡1¡G
¡@½Õ¾ã¥Dn¦@Åܶµ |
| ¤£¹B°ÊªÌ | $1015 | 23.6% | 7.3% |
| ¨Å鬡°Ê¶q¤£¨¬ªÌ | $603 | 14.0% | 2.7% |
| ¨Å鬡°Ê¨¬°÷ªÌ | -- | -- | 9.9% |
¼Ò¦¡2¡G
¡@½Õ¾ã¥Dn¦@Åܶµ©MBMI |
| ¤£¹B°ÊªÌ | $920 | 20.9% | 6.6% |
| ¨Å鬡°Ê¶q¤£¨¬ªÌ | $482 | 10.9% | 2.1% |
| ¨Å鬡°Ê¨¬°÷ªÌ | -- | -- | 8.7% |
µù¡G½Õ¾ãªº¦@Åܶµ (¥]¬A©Ê§O¡B¦~ÄÖ¡BºØ±Ú¡B«°¶m¡B½Õ¬d¦a°Ï¡Bµ²±Bª¬ªp¡B±Ð
¡@¡@¨|¡B³h½a¤ô·Ç¡B°·±d«OÀI¡B©â·Ï©MMEPSµ¥) ©MBMI (¨Åé½è¶q«ü¼ÆÃþ§O)¡C
¡@¡@5. ¦pªG¥h°£¦]¬°°·±d¦Ó¨S¦³¿ìªk¨«¸ôªÌ¡A¦b½Õ¾ã¥Dn¦@Åܶµ©MBMI«á¡A¬ù¦³8.7% ªº¾ãÅé°·±d·ÓÅ@¤ä¥X»P¨Å鬡°Ê¶q¤£¨¬ (¨S¦³¹B°Ê»P¹B°Ê¤£¨¬) ¦³Ãö¡C¨C¦ì¤£¹B°ÊªÌªº°·±d·ÓÅ@¤ä¥X¡A¤ñ¨Å鬡°Ê¨¬°÷ªÌ¡A¨C¦~¼W¥[920¬ü¤¸¡A¬Û®t20.9%¡F¦Ó¤ñ¨Å鬡°Ê¶q¤£¨¬ªÌ¡A¨C¦~¼W¥[¤ä¥X482¬ü¤¸¡A®t²§10.9%¡A¦U¨Å鬡°Ê²Õ§O¶¡ªº°·±d·ÓÅ@¤ä¥X¬Ò¹FÅãµÛ®t²§ (¦pªí2¡A¼Ò¦¡2)¡C
¡@¡@µ²½×»P°Q½×¡C1. ¥Á²³¯à¾i¦¨³W«ß¹B°Ê²ßºD¡A©Î©ó¥Í¬¡¤¤¼W¥[¨Å鬡°Ê¶q¡A¤£¦ý¦³¯q¨¤ß°·±d¡A¥ç¥i¸`¬Ù°·±d·ÓÅ@¶O¥Î¡C2. ¨Å鬡°Ê¶q¤£¨¬·|©úÅã¼W¥[°·±d·ÓÅ@¸g¶Ot¾á¡C¨C¶g¦Ü¤Ö±q¨Æ¤¤µ¥¦Ü¿E¯P±j«×ªº¹B°Ê150¤ÀÄÁªÌ (¨Ì¤£¦Pªº¤ÀªR¼Ò¦¡)¡A¤ñ¹B°Ê¤£¨¬ªÌ¨C¦~¬ù´î¤Ö10%ªº°·±d·ÓÅ@¤ä¥X (8.7-12.5%)¡F¦³¾A«×¨Å鬡°Ê (¨C¶g150¤À¥H¤W) ªÌ¡A¨C¤H¨C¦~ªº°·±d·ÓÅ@¤ä¥X¤ñ¨S¦³¨Å鬡°ÊªÌ´î¤Ö20-30%¡A¤ñ¨Å鬡°Ê¤£¨¬ªÌ´î¤Ö10.9-15.4%¡C3. ¥»¬ã¨s¹ï¶H¬°«D¾÷ºc¦í¥Á¡A¦p¬O¾÷ºc¦í¥Á (¦í¦bÂå°|©Î°ªÄÖ·ÓÅU¾÷ºcµ¥)ªº¥Á²³¡A¦b°·±dª¬ªp¸û®tªº±¡ªp¤U¡A¨C¦~°·±d·ÓÅ@¤ä¥X·|¬Û¹ï¼W¥[¡A¨Å鬡°Êªº¼vÅTµ{«×±N·|¦³©Ò¤£¦P¡C4. ¥»¬ã¨sªº¨Å鬡°Ê¶q¥uµû¶q¥ð¶¢®É¶¡¡A·|§C¦ô¨CÓ¤Hªº¨Å鬡°Ê¶q¡A¦pªG¥]¬A¤W¯Z©Î¤u§@®É¶¡ªº¨Å鬡°Ê¶q¡A«h¸û¬°§¹¾ã¡C5. ¥»¬ã¨s¥uµû¦ô¨Å鬡°Ê¹ï°·±d·ÓÅ@¤ä¥X¡A¨S¦³¦ôp¨ä¥L¶¡±µªº¼vÅT¡A¦p¹B°Ê¤£¨¬¹ï¤u§@»P¥Í²£®Ä²v²£¥Ít±¼vÅT¡A©Î¬O¾ÉP¦¦º©Î¥¢¯à©Ò²£¥Íªº¼vÅTµ¥¡C6. °Ý¨÷¦Ûµªªº¨Å鬡°Ê¶q·|¦³°¾®t²{¶H¡A¶ñµªªÌ¦³°ª¦ô¨Å鬡°Ê¶qªºÁͦV¡A¦p°ª¦ô¨Å鬡°Ê¶q´N·|§C¦ôÂåÀø¤ä¥X¡C
°Ñ¡B¤ß¦åºÞ¯e¯f»P¨Å鬡°Ê©MÂåÀø¤ä¥X
¡@¡@¦³¤ß¦åºÞ¯e¯f (cardiovascular disease, CVD) »PCVD¦MÀI¦]¯À·|¼W¥[ÂåÀø¤ä¥X¡H¨Å鬡°Ê¶q¬O§_·|´î§CCVD©ÎCVD¦MÀI¦]¯À±wªÌªºÂåÀø¸g¶O¡H¤@½gµoªí©ó¬ü°ê¤ßŦ¨ó·|Âø»xªº½×¤å (Valero-Elizondo et al., 2016)¡A±´°Q¨Å鬡°Ê¹ïCVD»PCVD¦MÀI¦]¯À±wªÌªºÂåÀø½ÄÀ»¡A¸Ó¬ã¨s¥Øªº¡B¬ã¨s¤èªk¡Bµ²ªG»Pµ²½×µ¥¶µ¥Ø¡A»¡©ú¦p¤U¡C
¡@¡@ ¬ã¨s¥Øªº¡G¹L¥h«Ü¤Ö¦³¬ã¨s±´°Q¨Å鬡°Ê¹ïCVD©ÎCVD¦MÀI¦]¯À±wªÌÂåÀø¤ä¥X»P¸ê·½¨Ï¥Îªº¼vÅT¡A¦¹¬ã¨s¥Øªº¤ñ¸û¦³µL¾A«×¨Å鬡°Ê¡A¦b¦³µLCVD¡B¤£¦PCVD¦MÀI¦]¯ÀªÌÂåÀø¶O¥Î©M¸ê·½¨Ï¥Îªº®t²§¡C°ò¥»ªº¬ã¨s°²³]¬O¡G±q¨Æ¾A«×¨Å鬡°ÊªÌªºÂåÀø¶O¥Î©M¸ê·½¨Ï¥Î·|¤ñ¹B°Ê¤£¨¬ªÌ¤Ö¡C
¡@¡@¬ã¨s¤èªk¡G¦³Ãöªº¤èªk»P¤º®e¦p¤U¡C1. ¬ã¨s¹ï¶H¡G¦¹¬ã¨s18·³¥H¤W«D±µ¨ü¾÷ºc¦¡·ÓÅUªº¬ü°ê¦¨¦~¤H (non-institutionalized adults) ¬°¹ï¶H¡A±Æ°£µLªk¨«¤Q¨B¸ô©ÎÃh¥¥°ü¤k¡A¦³26239 ¦ì°Ñ»P¦¹½Õ¬d¬ã¨s¡C2. CVD±wªÌ¡G°Ñ»PªÌ¦p³Q¶EÂ_¦³«aª¬°Ê¯ß¯e¯f¡B¤¤·¡B¤ßŦ°IºÜ¡B¤ß«ß¤£¾ã©Î¶gÃä°Ê¯ß¯e¯f´N³QÂkÃþ¬°CVD±wªÌ¡C3. CVD¦MÀI¦]¯Àµ¥¯Å¡G¥H¦Û§Ú°Ý¨÷½Õ¬d°Ñ»PªÌ¦³¦h¤ÖCVD¦MÀI¦]¯À (cardiovascular disease risk factor, CRF)¡A¥]¬A°ª¦åÀ£¡B¿}§¿¯f¡BÁx©T¾J¹L°ª¡B©â·Ï©Î¨Åé½è¶q²Õ¼Æ¹L°ª (BMI ≥30 kg/m
2)¡C¨Ì³o¨Ç¦]¯À¦h¹è¥[¥H¤ÀÃþ¡A¦p¶W¹L©Îµ¥©ó¤TÓ¡A«h³QÂkÃþ¬°¡u¤£¦n¡vµ¥¯Å¡A¨âÓ¬°¡u´¶³q¡v¡A0-1Ó«h¬°¡u²z·Q¡vµ¥¯Å¡C 4. ¨Å鬡°Ê¶qµ¥¯Å¡G°Ñ»PªÌ¦^µª¤U¦C°ÝÃD¡A¡u§A³Ìªñ¨C¶g¦³±q¨Æ¦Ü¤Ö¤¤Ñ¡A¨C¤Ñ30¤ÀÄÁ¥H¤Wªº¤¤µ¥¦Ü¿E¯P¹B°Ê¡H¡v¡A¦p¦^µª¬O¡A«hÂk¬°¡u¾A«×¨Å鬡°Ê¡vµ¥¯Å; ¦pµª§_¡A«hÂk¬°¡u¨Å鬡°Ê¤£¨¬¡vµ¥¯Å¡C5. °·±d·ÓÅ@¤ä¥X: ¨C¤H¨C¦~¾ãÅ骺ÂåÀø¤ä¥X (medical expenditures) ª½±µ¥Ñ¬ÛÃö¸ê®Æ¥[¥H¦ôp¡A¥]¬A©Ò¦³ÂåÀø·ÓÅU¨t²Î¤ä¥I©MÓ¤H¤ä¥Xªº¸g¶O¡A§t¦í°|¡B¥X°|¡B³B¤èÃÄ©M¥®Éªù¶E¡B«æ¶E©M¨ä¥L¤ä¥X (¦p¬Ý¤ú¬ì¡B²´¬ì¡B®a®x°·±d·ÓÅ@¶O¥Î©M¨ä¥LÂåÀø¥Î«~µ¥)¡A¦Ó¥H2012¦~ÂåÀø¤ä¥X¤p²Õ½Õ¬dªº¸ê®Æ¥[¥H¤ÀªR¡C6. ÂåÀø¸ê·½¨Ï¥Î¡GÂåÀø¸ê·½¨Ï¥Î¥]¬A«æ¶E¡Bªù¶E¡B¦í°|¦¸¼Æ©MÃĪ«³B¤è¦¸¼Æµ¥¡C 7. ¦@Åܶµ (covariates)¡G¥»¬ã¨s¦¬¶°¬ÛÃö¦@Åܶµ¡A¥]¬A¦~ÄÖ¡B©Ê§O¡B®a®x¦¬¤J¡BºØ±Ú¡B¤u§@¡B«OÀIºØÃþ¡B¦a²z°Ï°ì©M¦X¨Ö¯g«ü¼Æ(comorbidity Index)µ¥¡C8. ¤£¦P¼Ò¦¡¤ñ¸û¤ÀªR¡G§Q¥Î¸gÀÙ¼Ò¦¡¨Ó¦ôp¨CÓ¤HªºÂåÀø¤ä¥X¡A¨Ã½Õ¾ã(adjust)©Î±±¨î¤£¦P¦@Åܶµªºª¬ªp¤U¡A¥H¤£¦Pªº¼Ò¦¡¥[¥H¤ÀªR¤ñ¸û¡A¥»¤å¥H¨âÓ¼Ò¦¡»¡©ú¡G ¼Ò¦¡1¡A¨S¦³½Õ¾ã¦@Åܶµ; ¼Ò¦¡2¡A½Õ¾ãªº¦@Åܶµ¡A¥]¬A¦~ÄÖ¡B©Ê§O¡B®a®x¦¬¤J¡BºØ±Ú¡B«OÀIºØÃþ¡B¦a²z¦ì¸m©M×¥¿¤§¦X¯f¯g«ü¼Æ («D¤ß¦åºÞ¯e¯fªº¦]¯À)¡C
¡@¡@µ²ªG¡G«nªº¬ã¨sµ²ªG¦p¤U¡C1. ¨ãCVD¦MÀI¦]¯À (CRF) ¤§°Ñ»PªÌ¤¤¡A¦³¾A«×¨Å鬡°ÊªÌ¤ñ¨Å鬡°Ê¶q¤£¨¬ªÌ¡A¬ù¥i´î¤Ö14-28%ªºÂåÀø¤ä¥X¡A¨ä¤¤¥HCRF¬°¤£¦nµ¥¯Å¡A¨Å鬡°Ê¤S¤£¨¬ªÌ¡AÂåÀø¤ä¥X7567¬ü¤¸³Ì°ª¡A¤Ï¤§CRF¬°²z·Qµ¥¯Å¡A¤S¦³¾A«×¨Å鬡°ÊªÌ¡AÂåÀø¤ä¥X2328¬ü¤¸³Ì§C¡A¤GªÌ¬Û®t3.2¿¡A¦U²Õ¤§¶¡§¡§eÅãµÛ®t²§ (ªí3¡A¼Ò¦¡1)¡C
ªí3¡G¨Å鬡°Ê¡BCRFµ¥¯Å©MÂåÀø¤ä¥X¤ñ¸ûªí
| ¨Å鬡°Ê¡BCRFµ¥¯Å/ÂåÀø¤ä¥X | CRF¤£¦n | CRF´¶³q | CRF²z·Q |
| ¼Ò¦¡1 |
| ¨Å鬡°Ê¤£¨¬ªÌ | $7567 | $5191 | $3053 |
| ¾A«×¨Å鬡°ÊªÌ | $5475 | $4476 | $2328 |
| ¼Ò¦¡2 |
| ¨Å鬡°Ê¤£¨¬ | $6339 | $4577 | $3733 |
| ¾A«×¨Å鬡°Ê | $5279 | $4147 | $3240 |
µù¡G¼Ò¦¡1¡A¨S¦³½Õ¾ã¦@Åܶµ¡F¼Ò¦¡2¡A½Õ¾ã¬ÛÃö¦@Åܶµ¡C
¡@¡@2. ¨ãCVD¦MÀI¦]¯À¡]CRF¡^¤§°Ñ»PªÌ¤¤¡A¦p¸g½Õ¾ã¦@Åܶµ«á¡A¦U²Õ¤§¶¡ªºÂåÀø¤ä¥X¤´¹FÅãµÛ®t²§¤ô·Ç(¦pªí3¡A¼Ò¦¡2)¡C§Y¦³¾A«×¨Å鬡°Ê¥BCRF¤S¬°²z·Qµ¥¯ÅªÌ¡A¨C¦~ªºÂåÀø¤ä¥X¬°¬üª÷3240¤¸¡A¤Ï¤§¡A¨âÓ¦]¯À¬Ò¤£¨ÎªÌ¡A«h¨C¦~ÂåÀø¤ä¥X´£°ª¦Ü¬üª÷6339¤¸¡A¬ù¼W¥[¤@¿¡C
¡@¡@3. ¦bCVD°Ñ»PªÌ¤¤¡A¦³µL¾A«×¨Å鬡°Ê¡A¨äÂåÀø¤ä¥X»P¥þ³¡°Ñ»PªÌ¤§ÂåÀø¤ä¥X¤´¹FÅãµÛ®t²§¤ô·Ç¡C§Y¨Ï½Õ¾ã¬ÛÃöªº¦@Åܶµ¡A¾ãÅ骺ÁͶդ]«Ü±µªñ¡A¦pªí4¡C(1) CVD±wªÌ¤£ºÞ¦³µL¾A«×¨Å鬡°Ê¡A¨C¦~ÂåÀø¤ä¥X¬Ò¤ñ¥þ³¡°Ñ»PªÌ°ª¥X¬ù¤G¦Ü¤T¿¡A¤À§O¬°¦³¾A«×¬¡°ÊªÌ¤§10586©M3443¬ü¤¸¤Î¬¡°Ê¤£¨¬ªÌ¤§14569©M5397¬ü¤¸¡A¦pªí4¡A¼Ò¦¡1¡C(2) ¦ýCVD±wªÌ¦p¦³¾A«×¨Å鬡°Ê¡A¨C¦~ÂåÀø¤ä¥X¥i¥Ñ14659°¦Ü10586¬ü¤¸¡A¸`¬Ù4073¬ü¤¸¡A¬ù´î¤Ö27%¡F½Õ¾ã¦@Åܶµ«á¡A¥ç¥i¸`¬Ù2567¬ü¤¸¡A´î¤Ö20% ¡A¦pªí4¡A¼Ò¦¡1¤Î2¡C
ªí4¡GCVD±wªÌ©M¥þ³¡°Ñ»PªÌ¦³µL¾A«×¹B°ÊªºÂåÀø¤ä¥X¤ñ¸ûªí
| CVD¨Å鬡°Ê/ÂåÀø¤ä¥X | ¥þ³¡°Ñ»PªÌ | CVD±wªÌ |
| ¼Ò¦¡1 |
| ¨Å鬡°Ê¤£¨¬ | $5397 | $14659 |
| ¦³¾A«×¨Å鬡°Ê | $3443 | $10586 |
| ¼Ò¦¡2 |
| ¨Å鬡°Ê¤£¨¬ | $4867 | $12659 |
| ¦³¾A«×¨Å鬡°Ê | $4153 | $10092 |
µù¡G¼Ò¦¡1¡A¨S¦³½Õ¾ã¦@ÅܼơC¼Ò¦¡2¡A½Õ¾ã¬ÛÃö¦@Åܶµ¡C
¡@¡@4. CVD¡BCRFµ¥¯Å»P¨Å鬡°Êµ{«×¬Ò»PÂåÀø¸ê·½¨Ï¥Îª¬ªp¦³Ãö¡C(1) ¦¨¦~¤HµL½×¦³µLCVD©ÎCRFµ¥¯Å¦p¦ó¡A±q¨Æ¾A«×¨Å鬡°Ê¥i¥H°§C¦í°|ªº¾÷²v¡C(2) CVD°Ñ»PªÌ¤¤¡A¦pªG¨Å鬡°Ê¤£¨¬¡A¨ä¦í°|¤ñ²v»P¦¸¼Æ¬°27%©M1.4¦¸¡A¦p¦³¾A«×¨Å鬡°Ê¡A¨ä¦í°|¤ñ²v»P¦¸¼Æ°¬°21%»P1.2¦¸¡A¬Û®t6% (¦pªí5)¡C(3) ¦í°|¤ñ²v³Ì¤Öªº°Ñ»PªÌ¡A¬O¨SCVD¡BCRF²z·Qµ¥¯Å¤S¦³¾A«×¨Å鬡°Êªº¦¨¦~¤H¡A¦í°|¤ñ²v¬°2.6%¡C
ªí5¡G¤£¦PCVD©MCRFµ¥¯ÅªÌ¦³µL¾A«×¨Å鬡°Êªº¦í°|¤ñ²v¡B¦¸¼Æ¤ñ¸ûªí
¨Å鬡°Ê¡BCVD©M
CRFµ¥¯Å/¦í°|¦¸¼Æ | ¦³CVDªÌ | µLCVD©M
CRF¤£¦nªÌ | µLCVD©M
CRF´¶³qªÌ | µLCVD©M
CRF²z·QªÌ |
| ¾A«×¨Å鬡°Ê | 21%
1.2¦¸ | 7.9%
1.19¦¸ | 5.7%
1.23¦¸ | 2.6%
1.24¦¸ |
| ¨Å鬡°Ê¤£¨¬ | 27.2%
1.4¦¸ | 11.8%
1.34¦¸ | 8.0%
1.28¦¸ | 3.4%
1.21¦¸ |
µù¡G¦í°|ªº¥§¡¦¸¼Æ¬°¦³¥h¦í°|¤@¦¸¥H¤Wªº¥§¡¼Æ¡C
¡@¡@5. µL½×¦³©Î¨S¦³CVD©ÎCRFµ¥¯Å¦p¦ó¡A±q¨Æ¾A«×¨Å鬡°Ê§¡¥i¥H°§C«æ¶E (emergency department visits) ¤ñ²v»P¦¸¼Æ¡C(1)¦bCVD°Ñ»PªÌ¤¤¡A¦p¨Å鬡°Ê¤£¨¬¡A¨ä«æ¶E¤ñ²v©M¦¸¼Æ¤À§O¬°30.9%»P1.61¦¸¡A¦p¦³¨¬°÷¨Å鬡°Ê¡A«h°¬°24.1¢H»P1.47¦¸ (¦pªí6)¡C(2)¤TªÌ¬Ò²z·Q (§Y¨SCVD¡BCRF²z·Q©M¦³¾A«×¨Å鬡°Ê) ¦¨¦~¤Hªº«æ¶E¤ñ²v»P¦¸¼Æ³Ì¤Ö¡A¬°9.1%»P1.31¦¸¡C
ªí6¡G¨Å鬡°Ê¡BCVD©MCRFµ¥¯Å»P«æ¶E¤ñ²v¡B¦¸¼Æ¤ñ¸ûªí
¨Å鬡°Ê¡BCVD©M
CRFµ¥¯Å/«æ¶E¦¸¼Æ | ¦³CVDªÌ | µLCVD©M
CRF¤£¦nªÌ | µLCVD©M
CRF´¶³qªÌ | µLCVD©M
CRF²z·QªÌ |
| ¾A«×¨Å鬡°Ê | 24.1%
1.47¦¸ | 15.3%
1.31¦¸ | 12.5%
1.38¦¸ | 9.1%
1.31¦¸ |
| ¨Å鬡°Ê¤£¨¬ | 30.9%
1.61¦¸ | 18.8%
1.44¦¸ | 15.8%
1.45¦¸ | 9.2%
1.31¦¸ |
µù¡G«æ¶Eªº¥§¡¦¸¼Æ¬°¦³¥h«æ¶E¤@¦¸¥H¤Wªº¥§¡¼Æ¡C
¡@¡@6. µL½×¦³µLCVD©ÎCRFµ¥¯Å¦p¦óªº¦¨¦~¤H¡A±q¨Æ¾A«×¨Å鬡°Ê§¡¥i¥H°§Cªù¶E (outpatient visits) ¤ñ²v»P¦¸¼Æ(¦pªí7)¡C(1)¦bCVD±wªÌ¤¤¡A¦p¨Å鬡°Ê¤£¨¬¡A¨äªù¶E¤ñ²v©M¦¸¼Æ¤À§O¬°¬°95.6%»P14.9¦¸¡A¦p¦³¾A«×¨Å鬡°Ê¡A«h°¬°94.7¢H»P11.5¦¸¡C(2)ªù¶E¤ñ²v»P¦¸¼Æ³Ì¤Öªº¬O60.5%»P5.8¦¸¡A¬O¤TªÌ¬Ò²z·Q (§Y¨SCVD¡BCRF²z·Q©M±q¨Æ¾A«×¨Å鬡°Ê) ªº¦¨¦~¤H¡C
ªí7¡G¨Å鬡°Ê¡BCVD©MCRFµ¥¯Å»Pªù¶E¤ñ²v¡B¦¸¼Æ¤ñ¸ûªí
¨Å鬡°Ê¡BCVD©M
CRFµ¥¯Å/ªù¶E¦¸¼Æ | ¦³CVDªÌ | µLCVD©M
CRF¤£¦nªÌ | µLCVD©M
CRF´¶³qªÌ | µLCVD©M
CRF²z·QªÌ |
| ¾A«×¨Å鬡°Ê | 94.7%
11.5¦¸ | 85.0%
8.2¦¸ | 74.1%
7.9¦¸ | 60.5%
5.8¦¸ |
| ¨Å鬡°Ê¤£¨¬ | 95.6%
14.9¦¸ | 89.1%
9.9¦¸ | 81.0%
8.5¦¸ | 63.5%
6.8¦¸ |
µù¡G ¬Ý¶Eªº¥§¡¦¸¼Æ¬°¦³¥hªù¶E¤@¦¸¥H¤WªÌªº¥§¡¼Æ¡C
¡@¡@7. µL½×¦³©Î¨S¦³CVD©ÎCRFµ¥¯Å¦p¦óªº¦¨¦~¤H¡A±q¨Æ¾A«×¨Å鬡°Ê¥i¥H°§CÁʶR³B¤èÃĪ« (prescription medications) ¤ñ²v»P¦¸¼Æ (¦pªí8)¡C(1) ¦bCVD±wªÌ¤¤¡A¦p¨Å鬡°Ê¤£¨¬¡A¨äÁʶR³B¤èÃĪ«¤ñ²v©M¦¸¼Æ¤À§O¬°¬°97.3%»P45.9¦¸¡A¦p¦³¾A«×¨Å鬡°Ê¶q¡A«h°¬°97.2¢H»P31.9¦¸¡C(2) ³Ì¤ÖÁʶR³B¤èÃĪ«ªº¤ñ²v»P¦¸¼Æ¬O48.9%»P8.7¦¸¡A¬O¤TªÌ¬Ò²z·Q (§Y¨SCVD¡BCRF²z·Q©M±q¨Æ¾A«×¨Å鬡°Ê) ªº¦¨¦~¤H¡C
ªí8¡G¨Å鬡°Ê»PCVD©MCRFµ¥¯Å»PÁʶR³B¤èÃĪº¤ñ²v¡B¦¸¼Æ¤ñ¸ûªí
¨Å鬡°Ê»PCVD
©MCRFµ¥¯Å | ¦³CVDªÌ | µLCVD©M
CRF¤£¦nªÌ | µLCVD©M
CRF´¶³qªÌ | µLCVD©M
CRF²z·QªÌ |
| ¾A«×¨Å鬡°Ê | 97.2%
31.9¦¸ | 87.7%
24.9¦¸ | 76.6%
16.5¦¸ | 48.9%
8.7¦¸ |
¨Å鬡°Ê¤£¨¬ | 97.3%
45.9¦¸ | 91.7%
33.4¦¸ | 81.7%
19.4¦¸ | 53.5%
11.9¦¸ |
µù¡G ÁʶR³B¤èÃĪº¥§¡¤ñ²v©M¦¸¼Æ¬°¦³ÁʶR¤@¦¸¥H¤WªÌªº¥§¡¼Æ¡C
¡@¡@µ²½×¡C1. ¤ß¦åºÞ¯e¯f (CVD)¡BCRFµ¥¯Å©M¨Å鬡°Ê¬Ò·|¼vÅTÂåÀø¤ä¥X¡C2. ¨S¦³CVD¦¨¦~¤H¡A¦b¤TÓ¤£¦PCRFµ¥¯Å¡A¦p¦³¾A«×¨Å鬡°Ê¡A¤ñ¨S¦³¨¬°÷¹B°ÊªÌ¥i©úÅã´î¤Ö¬ù20%ªºÂåÀø¤ä¥X (14-28%)¡C3. ¨S¦³CVD¦¨¦~¤H¡A¦pCRFµ¥¯Å²z·Q¤S±q¨Æ¾A«×¨Å鬡°Ê¡A¨C¦~ªºÂåÀø¤ä¥X³Ì¤Ö¡A¬ù¬°CRFµ¥¯Å¤£¨Î¥B¨S¦³¨¬°÷¨Å鬡°ÊªÌªº1/2¦Ü1/3¡C4. CVD·|©úÅã¼W¥[ÂåÀø¤ä¥X¡ACVD¦¨¦~¤H¨C¦~ÂåÀø¤ä¥X¬ù¤@¯ë¤Hªº2.4 ¨ì3¿¡C5. CVD±wªÌ¦p±q¨Æ¾A«×¨Å鬡°Ê¡A¨C¦~¥iÅãµÛ´î¤Ö¬ù20%ªºÂåÀø¤ä¥X¡C6. CVD»PCRFµ¥¯Å©M¨Å鬡°Êµ{«×»PÂåÀø¸ê·½ªº¨Ï¥Î¦³Ãö¡AµLCVD¡B¦³¾A«×¨Å鬡°ÊªÌ¡A¨Ï¥Î³Ì¤ÖªºÂåÀø¸ê·½¡A¥]¬A¦í°|¡B«æ¶E¡Bªù¶E©MÁʶR³B¤èÃĪ«¡C
¸v¡B¤ßªÍ¥\¯à»P°·±d·ÓÅ@¤ä¥X
¡@¡@¤@Ó¤H¾Ö¦³¸û¨Î¤ßªÍ¥\¯à (cardiorespiratory fitness) ¬O§_¥i¥H´î¤ÖÂåÀø¤ä¥X©M¸ê·½¨Ï¥Î¡H¤¤¦~®É´Á¦³¦nªºÅé¾A¯à¡A¨ì¦Ñ¦~®ÉÂåÀø¶O¥Î¬O§_·|¤ñ¤@¯ë¤H§C¡H¤@½g¦b¬ü°ê¤ßŦ¾Ç·|Âø»xµoªíªº¤å³¹ (Bachmann et al., 2015) ¥H°lÂܤ覡¨Ó¦^À³³o¨Ç°ÝÃD¡A³o½g½×¤åªº¬ã¨s°Ê¾÷¡B¬ã¨s¥Øªº¡B¬ã¨s¤èªk¡Bµ²ªG©Mµ²½×¦p¤U¡C
¡@¡@¬ã¨s°Ê¾÷¡C¤ßªÍ¥\¯à¤SºÙ¬°¦³®ñ¾A¯à (aerobic fitness) ©Î¤ßªÍ¾A¯à¡A¬O¨Åé§l¤J¡B¹B°e©MÀ³¥Î®ñ®ðªº¯à¤O¡A ¥¦»P¨Å鬡°Ê¡B°·±dª¬ªp©M¤ß¦åºÞ¯e¯f¦³±K¤Á¬ÛÃö¡C¹L¥h¤Ö¦³¬ã¨s±´°Q¤ßªÍ¾A¯à¹ïÂåÀø¶O¥Îªº¼vÅT¡A§ó¤Ö¦³¬ã¨sªø´Á°lÂܤ¤¦~®É´Áªº¤ßªÍ¾A¯à¡A¹ï©ó±ß¦~®É´ÁÂåÀø¤ä¥Xªº¼vÅT¡C³o¬O²Ä¤@½gªø´Á°lÂܬã¨s¡A±´°Q¤¤¦~®É´Á¦³¸û°ªªº¤ßªÍ¥\¯à¬O§_¯à°÷´î¤Ö¦Ñ¦~®É´ÁªºÂåÀø¤ä¥X¡C
¡@¡@¬ã¨s¥Øªº¡C1. ¤ñ¸û¤£¦Pµ¥¯Å¤ßªÍ¥\¯à¤¤¦~¤H¡A¸g¹L22¦~«á¡A¦b¦Ñ¦~®É´Áªº°·±d·ÓÅ@¶O¥Î (health care cost) »PÂåÀø¸ê·½¨Ï¥Î¬O§_¦³©Ò®t²§¡C2. ¦b±±¨î¤ß¦åºÞ¯e¯f¤§¦MÀI¦]¯À«á¡A¤ñ¸û¤£¦Pµ¥¯Å¤ßªÍ¥\¯àªº¤¤¦~¤H¡A¸g¹L22¦~«á¡A©ó¦Ñ¦~®É´Áªº°·±d·ÓÅ@¶O¥Î»P¸ê·½¨Ï¥Î¨Ï§_¦³©Ò®t²§¡H
¡@¡@¬ã¨s¤èªk¡C1. ¬ã¨s³æ¦ì¡G¥»¬ã¨s¦b¬ü°ê¥j¬fªø´Á¬ã¨s¤¤¤ß (Cooper Center Longitudinal Study, CCLS) ¶i¦æ¡ACCLS©ó1970¦~¶}©l¡A¦b¬ü°ê¼w¦{¹F©Ô´µ±q¨Æªø´Á«e¤©Êªº°lÂܬã¨s¡C2. ¹ï¶H¡G¼x¨D19571¦ì¦bCCLS±µ¨ü°·±dÀˬdªº°·±dªÌ¬°¬ã¨s¹ï¶H (¥§¡¦~ÄÖ49·³)¡C³o¨Ç¥Á²³³QÁܽаѥ[³oÓ¬ã¨s¡A¸gÀò¨ä¦P·N«á±µ¨üÂåÀøÀˬd»P´ú¶q¡A¥]¬A¨ÅéÀˬd¡B¤HÅé´ú¶q¡BªÅ¸¡¦å²G¤ÀªR©M³Ì¤j¤ßªÍ¥\¯à´úÅç¡A¨Ã¶ñ¼gÓ¤H»P¥Í¬¡¤è¦¡¬ÛÃö¸ê®Æ¡C3. ¤ßªÍ¥\¯àÀË´ú»P¤ÀÃþ¡G°Ñ»PªÌ±µ¨ü¶]¨B¾÷´úÅç¡A¥H¶]¨B®É¶¡¨Óµû¦ô³Ì¤j¥NÁ¶q (maximal metabolic equivalents¡AMETs)¡A·í§@¤ßªÍ¥\¯à«ü¼Ð¡C¤ßªÍ¥\¯à¬O¥H¶]¨B¾÷´úÅç (Balke protocol) ªº³Ìªø®É¶¡¨Ó¥[¥H¦ôp¡A¥ÑMETs ªº¦h¹è¨Ó¥Nªí¡A¦ÓMETs¥i¥Ñ¶]¨B¾÷´úÅ窺¦^Âk¤½¦¡¦ôp¥X¨Ó¡AµM«á¨Ì¾Ú©Ê§O»P¦~ÄÖªº¼Ð·Ç±`¼Ò¡A±N¤ßªÍ¥\¯à¤À¬°¤µ¥¯Å¡A¦AÂk¬°¤T¤jÃþ¡G1) ¤ßªÍ¥\¯à¤£¨Î (Q1)¡A2) ¤ßªÍ¥\¯à´¶³q (Q2 to Q3)¡A¥H¤Î3) ¤ßªÍ¥\¯à¨}¦n (Q4 to Q5)¡C4. °·±d·ÓÅ@¶O¡G¦¹¬ã¨s¥HÂåÀø¼Ð·Ç¤ÀªRÀÉ®× (Medicare standard analytical files) ¬°°·±d·ÓÅ@¤ä¥Xªºµû¦ô¸ê®Æ¡C¥ÑÓ¤Hªº°ò¥»¸ê®Æ (ªÀ·|¦w¥þ¸¹½X©M¥X¥Í¦~¤ë¤é)¡A§Y¥iÀò¨ú©Ò«O¦sªºÂåÀø·ÓÅU¸g¶O¡C¬ã¨s¦¬¶°1999¨ì2009¦~¶¡´Á¶¡ªº¸ê®Æ¡A¾ãÅ骺ÂåÀø·ÓÅ@¸g¶O¥§¡¦³6.5¦~¡CCCLSµ²¦X½Õ¬d¹ï¶H¤¤¦~®É´Á (¥§¡¦~ÄÖ49·³) ¤ßªÍ¥\¯à¸ê®Æ»P¦Ñ¦~®É´Á (¥§¡¦~ÄÖ71·³¡A°lÂÜ22¦~«á) ªºÂåÀø¶O¥Î¡A¤ÀªR¤ñ¸û¬ÛÃöÅܶµªº®t²§¡A°Ñ»PªÌªºÂåÀø¶O¥Î¥ÑCCLS°lÂܨ즺¤`¬°¤î¡C¾ãÅ骺ÂåÀø¤ä¥X¥]¬A¬F©²ªºÂåÀø¤ä¥X¡B«OÀI¤½¥q¤ä¥X©MÓ¤H¤ä¥Iªº¶O¥Î¡A³o¸ê®Æ¤ÀªR¤èªk©M¹L¥h¨Ï¥Îªº¤èªk¤@P¡C
¡@¡@¬ã¨sµ²ªG¡C1. 65·³¥H¤W¨k©Ê»P¤k©Ê©ó¤¤¦~®É¾Ö¦³¨}¦nªº¤ßªÍ¥\¯à¡A«h¨C¦~¥§¡¾ãÅé°·±d·ÓÅ@¶O¥Î¬ÒÅãµÛ§C©ó¤ßªÍ¾A¯à¤£¨ÎªÌ (¦pªí9)¡A¨k©Ê¤ßªÍ¥\¯à¨}¦nªÌ»P¤£¨ÎªÌ¥§¡¨C¦~°·±d·ÓÅ@¶O¥Î¤À§O¬°7569¬ü¤¸»P12811¬ü¤¸¡A®t²§ 5242¬ü¤¸´î¤Ö41%¡C¤k©Ê«h¤À§O¬°6065¬ü¤¸»P10029¬ü¤¸¡A®t²§3964¬ü¤¸´î¤Ö56%¡C¨âªÌ§¡§eÅãµÛ®t²§ (p < 0.001)¡C
ªí9¡G°ªÄ֪̤ߪͥ\¯à¦nÃa»P¨C¦~¥§¡°·±d·ÓÅ@¤ä¥X¤ñ¸ûªí
| °·±d·ÓÅ@¤ä¥X/¤ßªÍ¾A¯à | ¤ßªÍ¥\¯à
¨}¦nªÌ | ¤ßªÍ¥\¯à
¤£¨ÎªÌ | ®t²§ | ´î¤Ö% | »¡©ú |
| ¾ãÅé°·±d·ÓÅ@¤ä¥X | ¨k $7569
¤k $6065 | ¨k $12811
¤k $10029 | $5242
$3964 | 41%
56% | P < 0.001
P < 0.001 |
| ¤ßŦ¯f¦³Ãö°·±d·ÓÅ@¤ä¥X | ¨k $1458
¤k $804 | ¨k $3333
¤k $1633 | $1875
$829 | 56%
51% | P < 0.001
P < 0.001 |
µù¡GP < 0.001¥NªíÅãµÛ®t²§ (Åé¾A¯à¨}¦n»P¤£¨ÎªÌ¤ñ¸û¡A¨k¡B¤k©Ê¤À¶}¤ñ¸û)¡C
¡@¡@2. 65·³¥H¤W¨k©Ê»P¤k©Ê©ó¤¤¦~®É¾Ö¦³¸û¨Îªº¤ßªÍ¾A¯à¡A«h¥§¡¨C¦~¤ßŦ¯f¦³Ãö°·±d·ÓÅ@¶O¥Î¬ÒÅãµÛ§C©ó¤ßªÍ¾A¯à¤£¨ÎªÌ (¦pªí9)¡A¨k©Ê¤ßªÍ¥\¯à¨}¦nªÌ»P¤£¨ÎªÌ¨C¦~¥§¡°·±d·ÓÅ@¶O¥Î¤À§O¬°1458¬ü¤¸»P3333¬ü¤¸¡A®t²§1875¬ü¤¸¡A´î¤Ö56%¡C¤k©Ê«h¤À§O¬°804¬ü¤¸»P1633¬ü¤¸¡A®t²§829¬ü¤¸¡A´î¤Ö 51%¡C¨âªÌ§¡§eÅãµÛ®t²§ (p < 0.001)¡C
¡@¡@3. ¨k©Ê»P¤k©Ê©ó¤¤¦~®É¾Ö¦³¸û¨Îªº¤ßªÍ¾A¯à¡A«h¨C¦~¥§¡ÂåÀø¸ê·½¨Ï¥Î (¦í°|¤Ñ¼Æ©M¬Ý¶E¦¸¼Æ) ¬ÒÅãµÛ§C©ó¤ßªÍ¥\¯à¤£¦nªÌ (p < 0.001¡A¦pªí10)¡C¨k©Ê¤ßªÍ¥\¯à¨}¦nªÌ»P¤£¨ÎªÌ¨C¦~¥§¡¦í°|¤Ñ¼Æ¤À§O¬°1.2¤Ñ»P2.7¤Ñ¡A¤k©Ê«h¤À§O¬°0.8¤Ñ»P2.4¤Ñ¡F¨k©Ê¨C¦~¥§¡¬Ý¶E¦¸¼Æ¤À§O¬°5.5»P6.4¦¸¡A¤k©Ê«h¤À§O¬°6.1¦¸»P7.2¦¸¡C
ªí10¡G¤ßªÍ¾A¯àª¬ªp»P¨C¦~¦í°|¡Bªù¶E¨Ï¥Î¤ñ¸ûªí
| ¤ßªÍ¾A¯àª¬ªp/¦í°|¡Bªù¶E¨Ï¥Î | ¤ßªÍ¾A¯à
¨}¦nªÌ | ¤ßªÍ¾A¯à
¤£¨ÎªÌ | »¡©ú |
| ¨C¦~¥§¡¦í°|¤Ñ¼Æ | ¨k©Ê1.2¤Ñ
¤k©Ê0.8¤Ñ | ¨k©Ê2.7¤Ñ
¤k©Ê 2.4¤Ñ | P < 0.001
P < 0.001 |
| ¨C¦~¥§¡ªù¶E (Âå®v) ¦¸¼Æ | ¨k©Ê5.5¦¸
¤k©Ê6.1¦¸ | ¨k©Ê6.4¦¸
¤k©Ê7.2¦¸ | P < 0.001
P < 0.001 |
»¡©ú¡G P < 0.001¥NªíÅãµÛ®t²§ (¤ßªÍ¾A¯à¨}¦n»P¤£¨ÎªÌ¤ñ¸û¦³ÅãµÛ®t²§¡A¨k¤k©Ê¤À¶}¤ñ¸û)
¡@¡@4. ¦b±±¨î¤ß¦åºÞ¯e¯f¦MÀI¦]¯À«á¡A¤¤¦~¤H¦³¸û¨Î¤ßªÍ¾A¯à»P¸û§Cªº±ß¦~°·±d·ÓÅ@¶O¥ÎªºÅãµÛ®t²§¡C5. ¦b½Õ¾ã¤ß¦åºÞ¯e¯f¦MÀI¦]¯À«á¡A°ªĄ֪̈C¦~¥§¡°·±d·ÓÅ@¶O¥ÎÀHµÛ¤¤¦~®É´Á¤ßªÍ¥\¯àªº¼W¥[¦ÓÅãµÛ´î¤Ö¡A¨C¼W¥[¤@ÓMET (3.5 ml/Kg. min)¡A¨k©Ê´î¤Ö6.8%¡A¤k©Ê«h´î¤Ö6.7%°·±d·ÓÅ@¤ä¥X (p < 0.001)¡C
¡@¡@µ²½×¡C1. ¤¤¦~®É´Á¤ßªÍ¥\¯à¨}¦nªÌ¡A©ó¦Ñ¦~®É¨C¦~ªº¾ãÅé°·±d·ÓÅ@¶OÅãµÛ§C©ó¤ßªÍ¥\¯à¤£¨ÎªÌ¡A¬Û®t¬ù50%(41-56%)¡C2. ¤¤¦~®É¾Ö¦³¸û¨Îªº¤ßªÍ¾A¯à¡A©ó¦Ñ¦~®É¨C¦~¤ßŦ¯f¦³Ãö°·±d·ÓÅ@¶O¥ÎÅãµÛ§C©ó¤ßªÍ¥\¯à¤£¨ÎªÌ¡A¬Û®t¬ù53% (51-56%)¡C3. ¤¤¦~®É¾Ö¦³¸û¨Îªº¤ßªÍ¾A¯à¡AµL½×¨k¤k©Ê¦Ñ¦~®É¨C¦~¦í°|¤Ñ¼Æ©Mªù¶E¦¸¼Æ¬ÒÅãµÛ§C©ó¤ßªÍ¾A¯à¤£¨ÎªÌ¡C4. ±±¨î¤ß¦åºÞ¯e¯f¦MÀI¦]¯À«á¡A¤¤¦~®É¾Ö¦³¦³¸û¨Î¤ßªÍ¥\¯àªÌ¡A¦b¦Ñ¦~®Éªº°·±d·ÓÅ@¶O¥ÎÁÙ¬OÅãµÛ§C©ó¤ßªÍ¥\¯à¤£¨Î¦P©Ê§OªÌ¡A§Y¤ßªÍ¥\¯à¬O¼vÅT°·±d·ÓÅU¶O¥Îªº¿W¥ß¦]¯À¡A¤£¨ü¤ß¦åºÞ¯e¯f¦MÀI¦]¯Àªº¼vÅT¡C5. ¤¤¦~®É´Á¤ßªÍ¥\¯à¶V¦n¡A¦Ñ¦~®É´î¤ÖªºÂåÀø¶O¥Î¤ä¥X¶V¦h¡A¨C¼W¥[¤@ÓMET¡A¬ù¥i´î¤Ö¬ù6.7%ªº°·±d·ÓÅ@¶O¥Î¡C
¥î¡Bµ²»y©M«ØÄ³
¤@¡Bµ²»y
¡@¡@¥Ñ©ó¹L¥h¦³Ãö¨Å鬡°Ê¡BÅé¾A¯à©MÂåÀø¸g¶O»P¸ê·½¨Ï¥Îªº¬ã¨s¤£¦h¡A´Á±æ¥¼¨Ó¯à¦³§ó¦hªº¬ã¨s¡A¥]¬A¥xÆWªº¥»¤g¬ã¨s¡A«ùÄò±´°Q³oÃþijÃD¡A´£¨Ñ§ó¦h¤¸¡B§ó²`¤J©M§ó§¹¾ãªº¸ê°T¡C¥»¤åÂÔ´N¤Wz¤T½g¬ã¨s¤åÄmªº¥Dnµ²ªG¡A¾ã²z¦p¤U¡G
¡@¡@1. ¨Å鬡°Ê¨¬°÷ªÌ (¨C¶g¦Ü¤Ö±q¨Æ5¤Ñ¡A¨C¤Ñ30¤ÀÄÁ¥H¤W¤¤µ¥¦Ü¿E¯P¨Å鬡°Ê) ¤ñ¨Å鬡¤£¨¬ªÌ¡A¥i´î¤Ö¬ù10%ªº¾ãÅéÂåÀø¶O¥Î¤ä¥X¡C
¡@¡@2. ¤¤¦~®É´Á¤ßªÍ¥\¯à¯à¸û¨ÎªÌ¡A¥i¥HÅãµÛ´î¤Ö¦Ñ¦~®É´ÁªºÂåÀø¶O¥Î¤ä¥X¬ù50%¡F¤ßªÍ¥\¯à¶V¨Î¡A´î¤ÖªºÂåÀø¶O¥Î¤ä¥X¶V¦h¡C
¡@¡@3. ¨Å鬡°Ê¨¬°÷ªÌ¡A¥i¥HÅãµÛ´î¤ÖÂåÀø¸ê·½ªº¨Ï¥Î¡A¥]¬A«æ¶E¡Bªù¶E¡B¦í°|©M»â¨ú³B¤èÃĪ«¡C
¡@¡@4. ¤¤¦~®É´Á¤ßªÍ¥\¯à¨}¦nªÌ¡A¥i¥H©úÅã´î¤Ö¦Ñ¦~®É´ÁªºÂåÀø¸ê·½¨Ï¥Î¡A¥]¬A¦í°|¤Ñ¼Æ©Mªù¶E¦¸¼Æ¡C
¡@¡@5. ¤ß¦åºÞ¯e¯f¬O¼vÅTÂåÀø¤ä¥Xªº¿W¥ß¦]¯À¡A±wªÌ¤ñ°_¤@¯ë¤H·|ÅãµÛ¼W¥[2¦Ü3¿ªº°·±d·ÓÅ@¸g¶O¡C¦ý¦p±q¨Æ¨¬°÷¨Å鬡°Ê¥i¥H´î¤Ö20%ªºÂåÀø¶O¥Î¤ä¥X¡C
¤G¡B«ØÄ³
¡@¡@¥Ñ¥H¤Wªº¬ã¨sµ²ªG±oª¾¡A¨¬°÷¨Å鬡°Ê©Î¨}¦n¤ßªÍ¥\¯à¥i¥H©úÅã´î¤ÖÂåÀø¤ä¥X©M¸ê·½¨Ï¥Î¡A¦ý§Y¨Ï¤w¿©±wCVD©Î¦³CVD¦MÀI¦]¯À¡A¦p¦³¾A«×¨Å鬡°Ê¡A¤´¥i¥H´î¤Ö°·±d·ÓÅ@¶O¥Î¤ä¥X¡C¦]¦¹¡A«ØÄ³¥D¬FªÌ©M¬ÛÃö¤Hû¦b«ä¦Ò¦³®Ä¹B¥Î°·«O©Îªø·Ópµe¸g¶Oµ¥Ä³ÃD®É¡A¯à±N¹ªÀy¥Á²³¾i¦¨³W«ß¹B°Ê²ßºD¤§µ¦²¤»P¤èªk¡A¤@¨Ö¼f·V¦Ò¶q¡C¥H¤U´XÂI¡AÂÔ´£¨Ñ°Ñ¦Ò¡G
¡@¡@1. ±N¼W¥[¨Å鬡°Ê»PÅé¾A¯à«P¶i¯Ç¤J«ÂI¬Fµ¦¡G¹ªÀy©M¨ó§U¥Á²³¾i¦¨°ÊºA¥Í¬¡¤è¦¡©M³W«ß¹B°Ê²ßºD¡A¿n·¥´£¤É°ê¥ÁªºÅé¾A¯à»P°·±dª¬ªp¡A¶i¦Ó¼W¥[°ê»ÚÄvª§¤O¡C³Ìªñ¤½§Gªº¡u¬ü°ê¨Å鬡°Ê«ü¾Éì«h¡v³ø§i®Ñ (U.S. Department of Health and Human Service, 2018)¡A´N¬O¥H¬F©²ªº¥ß³õ¡A§Æ±æ¬ÛÃö³æ¦ì¯à°÷¨Ì¾Ú³ø§i®Ñªº«ÂI©Mµ¦²¤¡AÀÀ©w¬ÛÃöpµe¨Ó¼W¥[°ê¤H¨Å鬡°Ê¶q¡A´£¤É¥Á²³Åé¾A¯à»P°·±dª¬ªp¡C
¡@¡@2. °w¹ï¤@¯ë¥Á²³¡A¹ªÀyÂǥѳW«ß¹B°Êºû«ù¨}¦n¤ßªÍ¥\¯à¡A¨C¶g±q¨Æ¦Ü¤Ö5¤Ñ¡A¨C¤Ñ30¤ÀÄÁ¥H¤W¤¤µ¥±j«×ªº¦³®ñ¹B°Ê¡A¦p§Ö¨«¡A©Î¬O¦Ü¤Ö¨C¶g3¤Ñ¡A¨C¤Ñ25¤ÀÄÁªº°ª±j«×¦³®ñ¹B°Ê¡A¦pºC¶]¡A¬Ò¥i¥H´£¤É¤ßªÍ¥\¯à¡A¦]¦ÓÀò±o³\¦h¨¤ß¯q³B¡A¥]¬A´î¤Ö¯e¯f¿©±w²v (¦pCVD) »PCVD¦MÀI¦]¯À¡C¦pªGµLªk«ùÄò¹B°Ê30¤ÀÄÁ¡A¤]¥i¥H¤À¬q¹ê¬I¡C
¡@¡@3. °w¹ï¯f¤H¡A«ØÄ³Âå®v¨Ì¾Ú¡u¹B°Ê´N¬O¨}ÃÄ (Exercise is Medicine)¡vªº²z©À¡A¬Ý¶E®É¯à±N¹B°Ê³B¤è¯Ç¬°ªvÀøªº¤@³¡¤À¡A¤Þ¾É¯f¤H¾i¦¨³W«ß¹B°Ê©Î¼W¥[¨Å鬡°Ê¶q¡A´N¯à³vº¥´£¤É¨äÅé¾A¯à¡A¨Ã§ïµ½¯e¯fª¬ªp¡C¬ü°ê°·±dºÖ§Q³¡³ø§i®Ñ«ü¥X¼W¥[¨Å鬡°Ê¶q¥i¥H´î¤Ö¿©±w³\¦h¯e¯fªº·ÀI¡A¥]¬ACVD¡B¿}§¿¯f¡B¥¢´¼»PÀù¯gµ¥¡A¤]¯à§ïµ½CVDªº¦MÀI¦]¯À (U.S. Department of Health and Human Service, 2018)¡C
¡@¡@4. °w¹ï°ªÄÖªøªÌ¡A«ØÄ³¬ÛÃö³æ¦ì°Ñ¦ÒÁp¦X°ê½Ã¥Í²Õ´¦b2015¡u°·±d¦Ñ¤Æ(healthy aging)¡v³ø§i¡A¨Ì¸Ó³ø§i¤§¬[ºc¡B²z©À»Pµ¦²¤¡A´£¥X¦³®Ä©M¨ãÅ骺¬Fµ¦»P¤èªk¡A¨ÓÀ°§U°ªÄ֪̾i¦¨°·±d¥Í¬¡¤è¦¡¡A±q¨Æ¾A«×¨Å鬡°Ê¡A¥Hºû«ù¨}¦n©Méwªº¨¤ß°·±d©M¨Åé¥\¯à¡A¦Ó¯à¿W¥ß¦Û¥D»P¥Í¬¡ (World Health Organization, 2015)¡C
¡@¡@5. ¬°«P¶i¥Á²³¹B°Ê²ßºDªº¾i¦¨¡A«ØÄ³n¦³¬ÛÃö¡u»¤¦]¡v¤§³]p¡C«e´¦¬ã¨s³ø§i«ü¥X¡A¨S¦³¨Å鬡°Ê¦¨¦~¤H¨C¦~¼W¥[¬ù20¢Hªº°·±d·ÓÅ@¤ä¥X¡A¦ý³o¨Ç¶O¥Î¡Aº·í¨ä½Äªº¬O°·«O¸g¶O¤Î¬F©²¤½°È¹wºâ¤ä¥X¡A¹ï¥Á²³¦Ó¨¥¡A¨ÃµL¤Ó¤j§Q®`Ãö«Y¡C¦]¦¹¡u»¤¦]¡v¤§³]p¦ü¦³¨ä¥²n©Ê¡A¦pÅé¾A¯à´£¤É©Î³W«ß¹B°Ê¨ì¬Yµ{«×¡A¯à°Ñ¦Ò¨ä¥L°ê®a¤§§@ªk¡A°u´î¥Á²³À³t¾á¤§°·±d«OÀI¶O²v©Î«O¶Oµ¥¡C¥H¹ê½èªº»¤¦]¡A¤Þ¾É¨ä¾i¦¨¹B°Ê²ßºD¡A«Ø¥ß¦Û¥D°·±dºÞ²z¤Î¦Û§Út³dªº¥¿½T²z©À¡C
¡@¡@6. ¹B°Ê²ßºDªº¾i¦¨«ÂI¦b¦æ¬°§ïÅÜ¡A¨ä¹Lµ{»Ý§Q¥Î¦æ¬°§ïÅܪkªº²z½×»Pµ¦²¤ (¤è¶i¶©¡A2019)¡A´£¤É¦Û§Ú®Ä¯à (Self-efficacy)¡A¦p´£¤É¹B°Ê±¡·N (¦pºA«×¡B¨É¨ü¹B°Ê)¡B»{ª¾ (¦pª¾¹D¹B°Ê¯q³B©M¤èªk) »P§Þ¯à (¦p¹B°Ê§Þ¥©)¡A¦Ó¯à¦b¥ô¦ó±¡¹Ò¡A¦³«O´¤¥i¦Û¤v¹B°Ê¡C¥~¦b¦]¯À¤]·|¼vÅT¹B°Ê¦æ¬°¡A¥]¬AªÀ·|¤ä«ù¡B¹B°Ê³õÀ]¡B½Òµ{»Ppµe¡BªÀ·|¤å¤Æ©Mªk«ß¨î«×µ¥¡C§Æ±æ²£©x¾Ç¬É¤@°_§V¤O¡A¼W¥[¥¿¦V¤¸¯À¡A¦P®É´î¤Öt±ªº»Ùê¡AÀ°§U¥Á²³¾i¦¨¹B°Ê²ßºD¡C
¡@¡@ºî¤W¡A´Á±æ¥»¤å©Ò´£¨Ñªº¬ã¨s¤åÄm»Pµ²ªG¡A¯à¿E°_ªÀ·|¤j²³¦@¦PÃö¤ß¨Å鬡°Ê©MÅé¾A¯à¹ï©óÂåÀø¸g¶O¤ä¥X©M¸ê·½§Q¥Îªº¼vÅT¡A¶i¦Ó§ó«µø¨Ã¸¨¹ê³W«ß¹B°Êªº¹ê½î¡A´£¤É°ê¥Á°·±d¡A¹F¦¨´î¤ÖÂåÀø¤ä¥X©M¸ê·½®ö¶O¤§¥Ø¼Ð¡C
¤Þ¥Î¤åÄm
¤è¶i¶© (2019)¡C¹B°Ê³B¤è¡C¤Gª©¡C¥x¥_¥«¡GµØ³£¡C
U.S. Department of Health and Human Servic (2018). Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Service.
Carlsona, S. A., Fultona, J. E., Pratta M., Yangb, Z., & Adams, E. K. (2015). Inadequate physical activity and health care expenditures in the United States. Progress In Cardiovascular Diseases, 5(7), 315-323.
Valero-Elizondo, J., Salami, J. A., Osondu, C. U., Ogunmoroti, O., Arrieta, A., Spatz, E. S., Younus, A., Rana, J. S., Virani, S. S., Blankstein, R., Blaha, M. J., Veledar, E., & Nasir, K. (2016). Economic impact of moderate-vigorous physical activity among those with and without established cardiovascular disease: 2012 medical expenditure panel survey. Journal American Heart Association, 5, e003614.
Bachmann, J. M., DeFina, L. F., Franzini, L., Gao, A., Leonard, D. S., Cooper, K. H., Berry, J. D., & Willis, B, L. ( 2015). Cardiorespiratory fitness in middle age and health care costs in later life. Journal of The American College of Cardiology. 66(17), 735-1097.
World Health Organization. (2015). World Report on Ageing and Health. Retrieved from http://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf?sequence=1